期刊文献+

新型肝靶向载体[(2-乳糖酰胺基)乙胺基]甲酸胆固醇酯的合成与鉴定 被引量:1

Synthesis and characterization of a novel hepatotropic vector:[(2-lactoylamido) ethylamino] formic acid cholesterol ester
下载PDF
导出
摘要 目的将肝靶向基团半乳糖基引入到胆固醇结构中,制备[(2-乳糖酰胺基)乙胺基]甲酸胆固醇酯(CH-ED-LA)。方法以乳糖酸、乙二胺和胆固醇氯甲酯为原料,设计了内酯法和活性酯法2条合成路线,通过一系列酯化反应和酰化反应合成CH-ED-LA,采用IR、MS和NMR对其进行表征。结果采用工艺简单、收率较高的内酯法合成CH-ED-LA。结论CH-ED-LA是乙二胺与乳糖酸和胆固醇氯甲酯通过酰胺键连接的半乳糖化胆固醇衍生物。 Objective To incorporate liver-targeted galactosyl into cholesterol and prepare [ (2-1actoylamido) ethylamino]formic acid cholesterol ester (CH-ED-LA). Methods Internal-ester and activated-ester methods were designed. Lactobionic acid (LA), ethanediamine and cholesteryl chloroformate were chemically attached via the esterification and acylation reactions to produce [(2-1actoylamido) ethylamino] formic acid cholesterol ester (CH-ED-LA). The chemical structures were characterized by IR, MS, ^1H-NMR and :3C-NMR. Results CH-ED-LA was synthesized by internal-ester method which has simple preparation technique and high yield. Conclusions CH-ED-LA is the glycosyl galactose cholesterol derivative syntheisized from ethanediamine and cholesteryl chloroformate via amide linkage.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2007年第9期541-545,共5页 Journal of Shenyang Pharmaceutical University
基金 国家自然科学基金资助项目(30371694)
关键词 [(2-乳糖酰胺基)乙胺基]甲酸胆固醇酯 内酯法 活性酯法 肝靶向 化学合成 [ (2-1actoylamido) ethylamino] formic acid cholesterol ester internal-ester method activated-es- ter method ~ hepatocyte-targeting chemical synthesis
  • 相关文献

参考文献11

  • 1GENDELMAN H E,ORENSTEIN J M,BACA L M,et al.The macrophage in the persistence and pathogenesis of HIV infection[J].AIDS,1989,3:475-495.
  • 2PARANG K,WIEBE L I,KNAUS E E.Novel approaches for designing 5'-O-ester prodrugs of 3'-azido-2,3'-dideoxythymidine(AZT)[J].Curr Med Chem,2000,7(10):995-1039.
  • 3BHADRA D,YADAV A K,BHADRA S,et al.Glyco dendrimeric nanoparticlulate carriers of prirnaqurine phosphated for liver targeting[J].Int J Pharm,2005,295(1-2):221-233.
  • 4常桂民,段芳龄,盛剑秋,杨淑英.半乳糖脂修饰的脂质体靶肝特性实验研究[J].中华核医学杂志,1998,18(4):206-208. 被引量:8
  • 5KAWAKAMI S,YAMASHITA F,NISFIKAW M,et al.Asialoglyeoprotein receptor-mediated gene transfer using novel galactosyhted cationic liposomes[J].Biochem Biophys Res Commun,1998,252(1):78-83.
  • 6BIJSTERBOSCH M K,VAN BERKEL T J.Uptake of lactosylated low-density lipoprotein by galactose-specific receptors in rat liver[J].Biochem J,1990,270(1):233-239.
  • 7KIM C K,MIN K H,OH Y K,et al.Preparation and lectin binding characteristics of N-stearyl lactobion amide liposomes[J],Int J Pharm,1996,128(1-2):65-71.
  • 8俞开潮,万福贤,张焱,周锦兰,卢广,刘买利,丁尚武.新型胺羧单酯-酰胺钆配合物的合成及其对大鼠肝区T_1弛豫增强作用[J].无机化学学报,2004,20(4):389-393. 被引量:6
  • 9BIGG D C H,LESIMPLE P.Triethylamine/aluminum chloride promoted aminolysis of lactones:a useful method for the preparation of ω-hydroxyalkanamides[J].Synthesis,1992,3:227-228.
  • 10姚新生.有机化合物波谱解析[M].北京:中国医药科技出版社,1996..

二级参考文献16

共引文献24

同被引文献31

  • 1王庆伟,刘宏,吕惠兰,张学锋,程孝国.多烯紫杉醇靶向放疗增敏对结肠癌细胞凋亡及相关蛋白表达的影响[J].中国普通外科杂志,2007,16(4):331-334. 被引量:3
  • 2Guo S,Zheng J,Dong J. Iron/dextran sulfate multilayered microcapsules for control ed release of 10-hydroxycamptothecin[J].International Journal of Biological Macromolecules,2011,(03):409-415.
  • 3Zhang Y,Song WJ,Zhang FQ. Differentiation-inducing activity of hydroxycamptothecin on cancer stem-like cel s derived from hepatocel ular carcinoma[J].Digestive Diseases and Sciences,2011,(08):2473-2481.
  • 4Zhang G,Ding L,Renegar R. Hydroxycamptothecin-loaded Fe3O4 nanoparticles induce human lung cancer cel apoptosis through caspase-8 pathway activation and disrupt tight junctions[J].Cancer Science,2011,(06):1216-1222.
  • 5Wei W,Shi SJ,Liu J. Lipid nanoparticles loaded with 10-hydroxycamptothecin- phospholipid complex developed for the treatment of hepatoma in clinical application[J].Journal of Drug Targeting,2010,(07):557-566.
  • 6Liang B,Zheng C,Feng G. Experimental evaluation of inhibitory effect of 10-hydroxycamptothecin on hypoxia-inducible factor-1alpha expression and angiogenesis in liver tumors after transcatheter arterial embolization[J].Journal of Vascular and Interventional Radiology,2010,(10):1565-1572.
  • 7Zhang RW,Li YF,Cai QY. Preclin ical Pharm acology of the natural productant anticancer agent 10-hydroxycamptothecin,an inhibitor of topoisomerase[J].Cancer Chemotherapy and Pharmacology,1998,(07):257-567.
  • 8Wang SN,Deng YH,Xu H. Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin[J].European Journal of Pharmaceutics and Biopharmaceutics,2006.32-38.
  • 9Khan W,Kumar N. Drug targeting to macrophages using paromomycin- loaded albumin microspheres for treatment of visceral leishmaniasis:an in vitro evaluation[J].Journal of Drug Targeting,2011,(04):239-250.
  • 10Cho JK,Hong KY,Park JW. Injectable delivery system of 2-methoxyestradiol for breast cancer therapy using biodegradable thermosensitive poly (organophosphazene) hydrogel[J].Journal of Drug Targeting,2011,(04):270-280.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部